imlunestrant 200 MG (equivalent to imlunestrant tosylate 265.66 MG) Oral Tablet

RxCUI: 2725917
RxNorm name: imlunestrant 200 MG (equivalent to imlunestrant tosylate 265.66 MG) Oral Tablet
Display name: imlunestrant 200 MG (equivalent to imlunestrant tosylate 265.66 MG) Oral Tablet
Full name: imlunestrant 200 MG (equivalent to imlunestrant tosylate 265.66 MG) Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Inluriyo	IMLUNESTRANT	Eli Lilly and Company	5bc172e4-e8a2-441a-be52-279a7f890196	2026-06-04	Warnings, Adverse reactions	Exact identifier rxcui: 2725917

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
5bc172e4-e8a2-441a-be52-279a7f890196	imlunestrant 200 MG Oral Tablet [PSN] · imlunestrant 200 MG Oral Tablet [SCD] · imlunestrant 200 MG (equivalent to imlunestrant tosylate 265.66 MG) Oral Tablet [SY]	3	6	These highlights do not include all the information needed to use INLURIYO safely and effectively. See full prescribing information for INLURIYO. INLURIYO (imlunestrant) tablets, for oral use Initial U.S. Approval: 2025	20251120